Decreasing delayed cerebral infarction after aneurysmal subarachnoid hemorrhage using active blood clearance and prevention of delayed cerebral ischemia: results of a 16-year patient registry.

IF 3.5 2区 医学 Q1 CLINICAL NEUROLOGY
Roland Roelz, István Csók, Manou Overstijns, Marco Bissolo, Theo Demerath, Petra Cimflova, Ralf Watzlawick, Christian Scheiwe, Eva Rohr, Jürgen Buttler, Johannes Pöppe, Nicole Koch, Jürgen Beck, Peter C Reinacher
{"title":"Decreasing delayed cerebral infarction after aneurysmal subarachnoid hemorrhage using active blood clearance and prevention of delayed cerebral ischemia: results of a 16-year patient registry.","authors":"Roland Roelz, István Csók, Manou Overstijns, Marco Bissolo, Theo Demerath, Petra Cimflova, Ralf Watzlawick, Christian Scheiwe, Eva Rohr, Jürgen Buttler, Johannes Pöppe, Nicole Koch, Jürgen Beck, Peter C Reinacher","doi":"10.3171/2025.2.JNS242828","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Active clearance of intracranial blood by intrathecal irrigation, fibrinolysis, and application of vasodilatory drugs may prevent delayed cerebral infarction (DCI) after aneurysmal subarachnoid hemorrhage (aSAH). Starting in 2015, the authors gradually implemented four methods for active blood clearance and prevention of delayed cerebral ischemia (ABCD) using urokinase and nimodipine in clinical management. In this paper, the impact of a patient-tailored use of these methods on DCI prevention is reported.</p><p><strong>Methods: </strong>Nine hundred sixty consecutive patients with aSAH admitted between 2008 and 2023 were included. Patients admitted before October 2015 were managed according to international guidelines (before-ABCD cohort, n = 543). ABCD became available in October 2015 and was gradually implemented by four different methods (after-ABCD cohort, n = 417) in patients at high risk for DCI. Nine patients in the after-ABCD cohort who were enrolled in a randomized trial on ABCD and allocated to standard of care were excluded. Cranial imaging was reviewed by an independent board and infarcts were classified as early, iatrogenic, or delayed.</p><p><strong>Results: </strong>After October 2015, 139 (33.3%) of 417 patients were selected for ABCD and the amount of extravasated blood (Hijdra sum score) was the key factor for ABCD use. Stereotactic catheter ventriculocisternostomy was developed in October 2015 and used in 88 patients. Intraoperative placement of a cisternoventricular catheter via the fenestrated lamina terminalis was introduced in 2018 and used in 30 patients. In 2021, ventriculolumbar irrigation and lumbo-lumbar irrigation were developed and used in 18 and 3 patients, respectively. DCI occurred in 115 (21.2%) of 543 patients before versus 32 (7.7%) of 417 patients after ABCD implementation (p < 0.0001). The per-patient DCI burden declined from 38.6 to 11.7 cm3. Neurological outcome was improved in patients with a high blood load (Hijdra score ≥ 30), and 26% after ABCD versus 9% of patients before ABCD achieved a modified Rankin Scale score of 0-3 (p = 0.006).</p><p><strong>Conclusions: </strong>Implementation of ABCD was associated with a low complication rate and a decline of 70% in the per-patient DCI burden. Outcomes were significantly improved in patients with a high blood load.</p>","PeriodicalId":16505,"journal":{"name":"Journal of neurosurgery","volume":" ","pages":"1-11"},"PeriodicalIF":3.5000,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neurosurgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3171/2025.2.JNS242828","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Active clearance of intracranial blood by intrathecal irrigation, fibrinolysis, and application of vasodilatory drugs may prevent delayed cerebral infarction (DCI) after aneurysmal subarachnoid hemorrhage (aSAH). Starting in 2015, the authors gradually implemented four methods for active blood clearance and prevention of delayed cerebral ischemia (ABCD) using urokinase and nimodipine in clinical management. In this paper, the impact of a patient-tailored use of these methods on DCI prevention is reported.

Methods: Nine hundred sixty consecutive patients with aSAH admitted between 2008 and 2023 were included. Patients admitted before October 2015 were managed according to international guidelines (before-ABCD cohort, n = 543). ABCD became available in October 2015 and was gradually implemented by four different methods (after-ABCD cohort, n = 417) in patients at high risk for DCI. Nine patients in the after-ABCD cohort who were enrolled in a randomized trial on ABCD and allocated to standard of care were excluded. Cranial imaging was reviewed by an independent board and infarcts were classified as early, iatrogenic, or delayed.

Results: After October 2015, 139 (33.3%) of 417 patients were selected for ABCD and the amount of extravasated blood (Hijdra sum score) was the key factor for ABCD use. Stereotactic catheter ventriculocisternostomy was developed in October 2015 and used in 88 patients. Intraoperative placement of a cisternoventricular catheter via the fenestrated lamina terminalis was introduced in 2018 and used in 30 patients. In 2021, ventriculolumbar irrigation and lumbo-lumbar irrigation were developed and used in 18 and 3 patients, respectively. DCI occurred in 115 (21.2%) of 543 patients before versus 32 (7.7%) of 417 patients after ABCD implementation (p < 0.0001). The per-patient DCI burden declined from 38.6 to 11.7 cm3. Neurological outcome was improved in patients with a high blood load (Hijdra score ≥ 30), and 26% after ABCD versus 9% of patients before ABCD achieved a modified Rankin Scale score of 0-3 (p = 0.006).

Conclusions: Implementation of ABCD was associated with a low complication rate and a decline of 70% in the per-patient DCI burden. Outcomes were significantly improved in patients with a high blood load.

主动血液清除和预防迟发性脑缺血减少动脉瘤性蛛网膜下腔出血后迟发性脑梗死:一项16年患者登记的结果
目的:通过鞘内冲洗、纤维蛋白溶解和血管舒张药物积极清除颅内血液可预防动脉瘤性蛛网膜下腔出血(aSAH)后迟发性脑梗死(DCI)的发生。从2015年开始,作者逐步将尿激酶联合尼莫地平进行主动血液清除和预防延迟性脑缺血(ABCD)的四种方法应用于临床管理。在本文中,报告了患者量身定制使用这些方法对DCI预防的影响。方法:纳入2008年至2023年间连续入院的960例aSAH患者。2015年10月前入院的患者按照国际指南进行管理(abcd前队列,n = 543)。ABCD于2015年10月开始使用,并通过四种不同的方法(ABCD后队列,n = 417)在DCI高风险患者中逐步实施。在ABCD后队列中,9名患者被纳入ABCD随机试验,并被分配到标准治疗。颅成像由一个独立的委员会审查,梗死分为早期、医源性或延迟性。结果:2015年10月以后,417例患者中有139例(33.3%)选择了ABCD,外渗血量(Hijdra sum评分)是ABCD使用的关键因素。立体定向导尿管脑室-胸膜吻合术于2015年10月开发并应用于88例患者。术中通过开窗终末板放置池脑室导管于2018年引入,并在30例患者中使用。2021年,脑室-腰椎灌洗和腰腰椎灌洗分别被开发和应用于18例和3例患者。实施ABCD前543例患者中有115例(21.2%)发生DCI,而实施ABCD后417例患者中有32例(7.7%)发生DCI (p < 0.0001)。每位患者DCI负担从38.6 cm3下降到11.7 cm3。高血负荷患者的神经系统预后得到改善(Hijdra评分≥30),ABCD后26%的患者与ABCD前9%的患者达到了修改的Rankin量表评分0-3 (p = 0.006)。结论:ABCD的实施与低并发症发生率和每位患者DCI负担下降70%相关。高血负荷患者的预后显著改善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of neurosurgery
Journal of neurosurgery 医学-临床神经学
CiteScore
7.20
自引率
7.30%
发文量
1003
审稿时长
1 months
期刊介绍: The Journal of Neurosurgery, Journal of Neurosurgery: Spine, Journal of Neurosurgery: Pediatrics, and Neurosurgical Focus are devoted to the publication of original works relating primarily to neurosurgery, including studies in clinical neurophysiology, organic neurology, ophthalmology, radiology, pathology, and molecular biology. The Editors and Editorial Boards encourage submission of clinical and laboratory studies. Other manuscripts accepted for review include technical notes on instruments or equipment that are innovative or useful to clinicians and researchers in the field of neuroscience; papers describing unusual cases; manuscripts on historical persons or events related to neurosurgery; and in Neurosurgical Focus, occasional reviews. Letters to the Editor commenting on articles recently published in the Journal of Neurosurgery, Journal of Neurosurgery: Spine, and Journal of Neurosurgery: Pediatrics are welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信